184
Participants
Start Date
June 30, 2008
Primary Completion Date
December 31, 2008
Study Completion Date
December 31, 2008
florbetapir F 18
IV injection, 370MBq (10mCi), single dose
Research Site, Albany
Research Site, Jenkintown
Research Site, Winston-Salem
Research Site, Hallandale
Research Site, Miami Beach
Research Site, Sunrise
Research Site, West Palm Beach
Research Site, St. Petersburg
Research Site, Phoenix
Research Site, Sun City
Research Site, Scottsdale
Research Site, Tucson
Research Site, Costa Mesa
Research Site, New Haven
Research Site, Bennington
Lead Sponsor
Avid Radiopharmaceuticals
INDUSTRY